Bioanalysis Zone

Interview with Roland Staack (Roche) on the nomenclature for large molecule assays recently developed at Roche

0

We sat down with Roland Staack (Roche) at the latest EBF 8th Open Meeting discussing the confusion caused by the current nomenclature for large-molecule drugs, and how this confusion may lead to misleading ‘active’ drug data. Roland also details the descriptive nomenclature, based on the therapeutics functionality, developed and implemented at Roche.

Share:

Leave A Comment